Paradigm BioDevices completed its 25,000th case with the QuickDraw MIS Bone Harvester™. A single-use, sterile version of the system is slated for launch next week, and CE Mark approval is expected by year-end.
Results from independent study with QuickDraw found that 67% of patients could not tell that they had undergone a bone graft harvest procedure.
Paradigm BioDevices completed its 25,000th case with the QuickDraw MIS Bone Harvester™. A single-use, sterile version of the system is slated for launch next week, and CE Mark approval is expected by year-end.
Results from independent study with QuickDraw found that 67% of...
Paradigm BioDevices completed its 25,000th case with the QuickDraw MIS Bone Harvester™. A single-use, sterile version of the system is slated for launch next week, and CE Mark approval is expected by year-end.
Results from independent study with QuickDraw found that 67% of patients could not tell that they had undergone a bone graft harvest procedure.
Copy to clipboard 
